Karen Atkin
AstraZeneca
6
0
6
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Zhang Yingyuan, Prof.
Antibiotics Institute, Huashan Hospital Affilicated to Fudan University
Shared therapeutic areas:
Worked with same sponsors:
Prof. Ye
Tong Ji Hospital of Tongji Medical College of Huazhong University of Science and Technology
Shared therapeutic areas:
Worked with same sponsors:
Prof. Na
Peking University Shougang Hospital
Shared therapeutic areas:
Worked with same sponsors:
Mentha Wang
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Louis Zhang
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Xu Johnson
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Shen Zhenzhou, Prof
Fudan University
Shared therapeutic areas:
Worked with same sponsors:
Longyun Li
Peking Union Medical College Hospital
Shared therapeutic areas:
Worked with same sponsors:
Aixia Wang, Prof.
Peiking Union Medical College Hospital
Shared therapeutic areas:
Worked with same sponsors:
Yanjing Zhang
AstraZeneca
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
The Performance of Patient Support Program in Early Stage Breast Cancer
China Registration Study in Patients With Skin Infections
A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa
Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.
Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment
Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice
All 6 trials loaded